All News #Library
Quality
The FDA scolds Tianyu over repeat API production shortfalls
29 Sep 2022 //
FIERCEPHARMA
Manufacturing sites in Germany & China hit with warning letters
27 Sep 2022 //
ENDPTS
EU, US Ban Manufacturer use of Valsartan From China’s Zhejiang Huahai
29 Sep 2018 //
RAPS
EMA review of impurities in sartan medicines
22 Sep 2018 //
PRESS RELEASE
Investigation of Valsartan products for evidence of API contamination
19 Aug 2018 //
SWISSMEDIC
Update on review of valsartan medicines due to detection of NDMA
10 Aug 2018 //
EMA
Tainted valsartan has been on the market for 4 years, FDA discovers
09 Aug 2018 //
FIERCE PHARMA

Market Place
Sourcing Support